Tactile Systems Technology, Inc. (TCMD)
After hours: 04:14PM EDT
| Previous close | 36.40 |
| Open | 36.91 |
| Bid | 35.41 x 800 |
| Ask | 35.49 x 800 |
| Day's range | 35.25 - 37.37 |
| 52-week range | 34.10 - 64.53 |
| Volume | 224,929 |
| Avg. volume | 124,755 |
| Market cap | 702.272M |
| Beta (5Y monthly) | 1.59 |
| PE ratio (TTM) | 51.08 |
| EPS (TTM) | 0.69 |
| Earnings date | 08 Nov 2021 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 70.00 |
- GlobeNewswire
Tactile Medical to Release Third Quarter of Fiscal Year 2021 Financial Results on November 8, 2021
MINNEAPOLIS, Oct. 04, 2021 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq:TCMD), a medical technology company focused on developing medical devices for the treatment of underserved chronic diseases at home, today announced that third quarter of fiscal year 2021 financial results will be released after the market closes on Monday, November 8th. Management will host a conference call with a question and answer session at 5:00 p.m. Eastern Time on November 8th to d
- GlobeNewswire
Treace Medical Concepts Appoints New Directors
PONTE VEDRA, Fla., Oct. 04, 2021 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a commercial-stage orthopaedic medical device company driving a paradigm shift in the surgical treatment of Hallux Valgus (commonly known as bunions), today announced the appointment of Betsy Hanna and Deepti Jain to its Board of Directors effective October 1, 2021. “With decades of combined experience in healthcare leadership, Ms. Hanna and Ms. Jain strengthen the exp
- GlobeNewswire
Tactile Medical Announces Enrollment of First Patient in Randomized, Controlled Clinical Trial Evaluating the Effectiveness of Flexitouch® Plus for the Treatment of Head and Neck Lymphedema
MINNEAPOLIS, Sept. 30, 2021 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company focused on developing medical devices for the treatment of chronic diseases at home, today announced the enrollment of the first patient in a randomized, controlled clinical trial evaluating the effectiveness of its Flexitouch® Plus system for the treatment of head and neck lymphedema. “With the enrollment of our first patient, we are pleased to initia
